Corient Private Wealth LP purchased a new position in Ventas, Inc. (NYSE:VTR – Free Report) in the second quarter, Holdings Channel reports. The fund purchased 162,336 shares of the real estate investment trust’s stock, valued at approximately $14,416,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Dynamic Wealth Strategies LLC purchased a new stake in shares of Ventas during the 1st quarter worth $25,000. Wiser Advisor Group LLC acquired a new stake in Ventas in the third quarter valued at $27,000. Silvant Capital Management LLC purchased a new stake in Ventas during the 2nd quarter worth about $28,000. Meeder Asset Management Inc. acquired a new position in shares of Ventas during the 2nd quarter worth about $30,000. Finally, IFC & Insurance Marketing Inc. purchased a new position in shares of Ventas in the 4th quarter valued at about $30,000. Institutional investors and hedge funds own 94.18% of the company’s stock.
Wall Street Analyst Weigh In
VTR has been the subject of several recent analyst reports. KeyCorp boosted their target price on Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Royal Bank Of Canada boosted their price objective on shares of Ventas from $98.00 to $99.00 and gave the stock an “outperform” rating in a research report on Friday, August 14th. Wells Fargo & Company increased their target price on shares of Ventas from $93.00 to $96.00 and gave the company an “overweight” rating in a research report on Monday, June 1st. Weiss Ratings raised shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, July 21st. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $100.00 price objective on shares of Ventas in a report on Tuesday, June 16th. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Ventas has an average rating of “Moderate Buy” and a consensus target price of $98.00.
Insider Buying and Selling
In other Ventas news, Director Michael J. Embler bought 2,500 shares of Ventas stock in a transaction dated Wednesday, June 3rd. The stock was acquired at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the acquisition, the director owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.53% of the company’s stock.
Ventas Stock Performance
Shares of VTR opened at $91.78 on Friday. The company’s 50 day simple moving average is $92.42 and its 200-day simple moving average is $87.57. The firm has a market cap of $47.08 billion, a PE ratio of 169.96, a price-to-earnings-growth ratio of 2.11 and a beta of 0.69. Ventas, Inc. has a 12-month low of $66.38 and a 12-month high of $101.60. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86.
Ventas (NYSE:VTR – Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 EPS for the quarter, beating the consensus estimate of $0.96 by $0.01. The firm had revenue of $1.73 billion during the quarter, compared to the consensus estimate of $1.68 billion. Ventas had a net margin of 4.08% and a return on equity of 1.99%. Ventas’s revenue for the quarter was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.87 EPS. As a group, equities analysts predict that Ventas, Inc. will post 3.89 EPS for the current year.
Ventas Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Further Reading
- Five stocks we like better than Ventas
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
